Article
Immune complexome analysis reveals the specific and frequent presence of immune complex antigens in lung cancer patients: A pilot study
29 Sept 2016
Abstract excerpt
Cancer immunotherapies such as antibodies targeting T cell checkpoints, or adaptive tumor-infiltrating lymphocyte (TIL) transfer, have been developed to boost the endogenous immune response against human malignancies. However, activation of T cells by such antibodies can lead to the risk of autoimmune diseases. Also, the selection of tumor-reactive T cells for TIL relies on information regarding mutated antigens...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
